After adjusting for gender, age, location, tumor size, TNM stage, as well as differentiation, it was indicated in multivariate analysis that the expression of PAX8 was an isolated risk factor for the survival of PC patients (P = 0.013; 95% CI, 1.083–4.316; HR, 2.337). The gene discussed is PAX8; the disease is pachyonychia congenita.